Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
UBS
Cantor Fitzgerald
Johnson and Johnson
Covington
Deloitte
Farmers Insurance
Colorcon
McKinsey
Julphar

Generated: January 16, 2018

DrugPatentWatch Database Preview

Alcaftadine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for alcaftadine and what is the scope of alcaftadine patent protection?

Alcaftadine
is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Alcaftadine has forty patent family members in twenty-eight countries.

There are five drug master file entries for alcaftadine. Three suppliers are listed for this compound.
Summary for alcaftadine
International Patents:40
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 5
Suppliers / Packagers: 3
Bulk Api Vendors: 33
Clinical Trials: 4
Patent Applications: 58
Drug Prices:see low prices
DailyMed Link:alcaftadine at DailyMed
Pharmacology for alcaftadine

US Patents and Regulatory Information for alcaftadine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan LASTACAFT alcaftadine SOLUTION/DROPS;OPHTHALMIC 022134-001 Jul 28, 2010 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for alcaftadine

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Merck
Novartis
Moodys
Deloitte
Accenture
Citi
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot